Synergistic effect of dendritic cell vaccination and anti-CD20 antibody treatment in the therapy of murine lymphoma. Apr 2009 - J. Immunother.; 32(4):1537-4513 [PMID:19342972] [Gadri Z] [Kukulansky T] [Bar-Or E] [Haimovich J] [Hollander N]
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study. Jan 2009 - Blood; 113(1):1528-0020 [PMID:18809757] [Di Nicola M] [Zappasodi R] [Carlo-Stella C] [Mortarini R] [Pupa SM] [Magni M] [Devizzi L] [Matteucci P] [Baldassari P] [Ravagnani F] [Cabras A] [Anichini A] [Gianni AM]
Therapeutic vaccines for non-Hodgkin B-cell lymphoma. Sep 2008 - ; 10(9):1699-048X [PMID:18796371] [Briones J]
Dendritic cells and T lymphocyte interactions in patients with lymphoid malignancies. Jul 2008 - Physiol Res; 57(2):0862-8408 [PMID:17552881] [Pytlík R] [Hofman P] [Kideryová L] [Cervinková P] [Obrtlíková P] [Sálková J] [Trnený M] [Klener P]
Immunotherapy of hematological malignancies using dendritic cells. Apr 2008 - Bull Cancer; 95(3):1769-6917 [PMID:18390412] [Van de Velde AL] [Berneman ZN] [Van Tendeloo VF]
Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo. Jan 2008 - Blood; 111(3):0006-4971 [PMID:17993615] [Franki SN] [Steward KK] [Betting DJ] [Kafi K] [Yamada RE] [Timmerman JM]
Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond. Jan 2008 - Am. J. Hematol.; 83(2):0361-8609 [PMID:17722077] [Zhou Y] [Zhang L] [Romaguera J] [Delasalle K] [Han X] [Du X] [Kwak L] [Yi Q] [Wang M]
Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis. Nov 2007 - J Transl Med; 5:1479-5876 [PMID:17894866] [Korthals M] [Safaian N] [Kronenwett R] [Maihöfer D] [Schott M] [Papewalis C] [Diaz Blanco E] [Winter M] [Czibere A] [Haas R] [Kobbe G] [Fenk R]
Comparison of dendritic cell-mediated immune responses among canine malignant cells. Oct 2007 - J. Vet. Med. Sci.; 69(9):0916-7250 [PMID:17917377] [Tamura K] [Arai H] [Ueno E] [Saito C] [Yagihara H] [Isotani M] [Ono K] [Washizu T] [Bonkobara M]
Induction of protective CTL immunity against peptide transporter TAP-deficient tumors through dendritic cell vaccination. Sep 2007 - Cancer Res.; 67(18):0008-5472 [PMID:17875682] [Chambers B] [Grufman P] [Fredriksson V] [Andersson K] [Roseboom M] [Laban S] [Camps M] [Wolpert EZ] [Wiertz EJ] [Offringa R] [Ljunggren HG] [van Hall T]
Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine. Mar 2007 - J Transl Med; 5:1479-5876 [PMID:17359532] [Adam C] [Mysliwietz J] [Mocikat R]
Generation of functional dendritic cells (DC) in adult acute lymphoblastic leukemia: rationale for a DC-based vaccination program for patients in complete hematological remission. Feb 2007 - Leuk. Lymphoma; 48(2):1042-8194 [PMID:17325890] [Maggio R] [Peragine N] [Calabrese E] [De Propris MS] [Intoppa S] [Della Starza I] [Ariola C] [Vitale A] [Foà R] [Guarini A]
Gene expression in enhanced apoptosis of human lymphoma U937 cells treated with the combination of different free radical generators and hyperthermia. Dec 2006 - Free Radic. Res.; 41(1):1071-5762 [PMID:17164180] [Wada S] [Tabuchi Y] [Kondo T] [Cui ZG] [Zhao QL] [Takasaki I] [Salunga TL] [Ogawa R] [Arai T] [Makino K] [Furuta I]
Current status of immunotherapy in B cell malignancies. Nov 2006 - Curr Drug Targets; 7(10):1873-5592 [PMID:17073599] [Kofler DM] [Mayr C] [Wendtner CM]
Antigen targeting to endosomal pathway in dendritic cell vaccination activates regulatory T cells and attenuates tumor immunity. Aug 2006 - Blood; 108(4):0006-4971 [PMID:16621963] [Maksimow M] [Miiluniemi M] [Marttila-Ichihara F] [Jalkanen S] [Hänninen A]
